Search Results - "Kemeny, M. Margaret"

Measurement invariance of intuitive cancer risk perceptions across diverse populations: The Cognitive Causation and Negative Affect in Risk scales by Baser, Raymond E, Li, Yuelin, Brennessel, Debra, Kemeny, M Margaret, Hay, Jennifer L

“…Intuitive cancer risk perceptions may inform strategies to motivate cancer prevention behaviors. This study evaluated factor structure and measurement…”
Get full text

Can a gastric cancer risk survey identify high-risk patients for endoscopic screening? A pilot study by In, Haejin, Langdon-Embry, Marisa, Gordon, Lauren, Schechter, Clyde B., Wylie-Rosett, Judith, Castle, Philip E., Margaret Kemeny, M., Rapkin, Bruce D.

“…A questionnaire that distinguishes how variability in gastric cancer prevalence is associated with ethnicity/birth country/immigration/cultural diet along with…”
Get full text

The impact of nativity on cervical cancer survival in the public hospital system of Queens, New York by Hagopian, George S., Lieber, Molly, Dottino, Peter R., Margaret Kemeny, M., Li, Xilian, Overbey, Jessica, Clark, Li-Duen, Beddoe, Ann Marie

“…We studied cervical cancer patients who presented to the Public Hospital System in ethnically-diverse Queens, New York from 2000 to 2010 with the purpose of…”
Get full text

Barriers to Clinical Trial Participation by Older Women With Breast Cancer by KEMENY, M. Margaret, PETERSON, Bercedis L, KORNBLITH, Alice B, MUSS, Hyman B, WHEELER, Judith, LEVINE, Ellis, BARTLETT, Nancy, FLEMING, Gini, COHEN, Harvey J

“…Although 48% of breast cancer patients are 65 years old or older, these older patients are severely underrepresented in breast cancer clinical trials. This…”
Get full text

Examining Intuitive Cancer Risk Perceptions in Haitian-Creole and Spanish-Speaking Populations by Hay, Jennifer L., Brennessel, Debra, Kemeny, M. Margaret, Lubetkin, Erica I.

“…Background: There is a developing emphasis on intuition and affect in the illness risk perception process, yet there have been no available strategies to…”
Get full text

Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases by Morikawa, Aki, de Stanchina, Elisa, Pentsova, Elena, Kemeny, Margaret M, Li, Bob T, Tang, Kendrick, Patil, Sujata, Fleisher, Martin, Van Poznak, Catherine, Norton, Larry, Seidman, Andrew D

“…Lapatinib and capecitabine cross the blood-tumor barrier in breast cancer brain metastasis but have modest clinical efficacy. Administration of high-dose…”
Get full text

The impact of nativity on uterine cancer survival in the public hospital system of Queens, New York by Hagopian, George S., Bapat, Alka Chintamani, Dottino, Peter R., Lieber, Molly, Kemeny, M. Margaret, Li, Xilian, Kaplowitz, Elianna, Beddoe, Annmarie

“…We studied cis-women with uterine cancer presenting to the two Public Hospitals in Queens, New York from 2006 to 2015 to examine the relationship between…”
Get full text

Sustaining CBPR partnerships to address health disparities in times of economic instability by Weiss, Elisa S, Stevenson, Alexis J, Erb-Downward, Jennifer, Combs, Sarah, Sabino, Eilleen E, Michel, Tamara A, Kemeny, M Margaret, Ackley-Kazdal, Tameron, O'Connor, Maureen, Rapkin, Bruce

“…In unstable economic environments, CBPR partnerships in underserved communities may face unanticipated obstacles that threaten success and sustainability. This…”
Get more information

Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602) by Freedman, Rachel A., Dockter, Travis J., Lafky, Jacqueline M., Hurria, Arti, Muss, Hyman J., Cohen, Harvey J., Jatoi, Aminah, Kemeny, M. Margaret, Ruddy, Kathryn J.

“…Background There are multiple known individual‐ and practice‐level barriers to enrollment of older patients with cancer to clinical trials, but little is known…”
Get full text

Having trouble making predictions: Comment on "Predicting disease progression after regional therapy for in-transit melanoma" by Kemeny, M Margaret

Get more information

Utilizing Cultural and Ethnic Variables in Screening Models to Identify Individuals at High Risk for Gastric Cancer: A Pilot Study by In, Haejin, Solsky, Ian, Castle, Philip E, Schechter, Clyde B, Parides, Michael, Friedmann, Patricia, Wylie-Rosett, Judith, Kemeny, M Margaret, Rapkin, Bruce D

“…Identifying persons at high risk for gastric cancer is needed for targeted interventions for prevention and control in low-incidence regions. Combining…”
Get full text

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292) by Kemeny, M. Margaret, Zhao, Fengmin, Forastiere, Arlene A., Catalano, Paul, Hamilton, Stanley R., Miedema, Brent W., Dawson, Nancy A., Weiner, Louis M., Smith, Brian D., Mason, Bernard A., Graziano, Stephen L., Gilman, Paul B., Venook, Alan P., Pinto, Harlan A., Whitehead, Robert P., O’Dwyer, Peter J., Benson, Al B.

“…Background Studies suggest that adjuvant chemotherapy should be initiated at the earliest possible time. The Eastern Cooperative Oncology Group (ECOG) and…”
Get full text

Deliberative and intuitive risk perceptions as predictors of colorectal cancer screening over time by Hay, Jennifer L., Ramos, Marcel, Li, Yuelin, Holland, Susan, Brennessel, Debra, Kemeny, M. Margaret

“…Cancer risk perceptions may involve intuitions—including both affect as well as gut-level thoughts about risk—and deliberative risk magnitudes. Yet, little…”
Get full text

The Influence of Vitamin D on Mammographic Density: Results from CALGB 70806 (Alliance) a Randomized Clinical Trial by Wood, Marie E, Liu, Heshan, Storrick, Elizabeth, Zahrieh, David, Le-Petross, H Carisa, Jung, Sin-Ho, Zekan, Patricia, Kemeny, M Margaret, Charlamb, Jayne R, Wang, Lili X, Unzeitig, Gary W, Johnson, Candace S, Garber, Judy E, Marshall, James R, Bedrosian, Isabelle

“…Current therapies for breast cancer prevention only prevent estrogen receptor positive (ER+) disease and toxicity limits use of these agents. Vitamin D is a…”
Get full text

Cancer beliefs and patient activation in a diverse, multilingual primary care sample by Hay, Jennifer L., Zabor, Emily C., Kumar, Julie, Brennessel, Debra, Kemeny, Margaret M., Lubetkin, Erica I.

“…Objectives Greater patient activation, defined as having the knowledge, skills, and confidence to manage one's health, is associated with cancer control…”
Get full text

Health literacy, information seeking, and trust in information in Haitians by Lubetkin, Erica I, Zabor, Emily C, Isaac, Kathleen, Brennessel, Debra, Kemeny, M Margaret, Hay, Jennifer L

“…To assess heath literacy, health information seeking, and trust in health-related information among Haitian immigrants seen in primary care. Health literacy…”
Get more information

Combined-Modality Treatment for Resectable Metastatic Colorectal Carcinoma to the Liver: Surgical Resection of Hepatic Metastases in Combination With Continuous Infusion of Chemotherapy—An Intergroup Study by Kemeny, M. M.

Get full text

How many patients and how many complications does it take to decide if a drug is safe to use before surgery? by Kemeny, M Margaret

Get full text

Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603) by Guerard, Emily, Dodge, Andrew B, Le-Rademacher, Jennifer G, Kemeny, M Margaret, Ojelabi, Michael, Sedrak, Mina S, Hopkins, Judith, Shahrokni, Armin, Harlos, Elizabeth, Muss, Hyman, Cohen, Harvey Jay, Lafky, Jacqueline, Sloan, Jeff, Jatoi, Aminah, Hurria, Arti

“…This study determined whether an electronic version of the geriatric assessment is feasible in a multi-institutional, diverse setting. Ten sites within the…”
Get more information

A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma by Shah, Manish A., Power, Derek G., Kindler, Hedy L., Holen, Kyle D., Kemeny, Margaret M., Ilson, David H., Tang, Laura, Capanu, Marinela, Wright, John J., Kelsen, David P.

“…Summary Purpose The transcription factor nuclear factor-kB (NFkB) is implicated in gastric cancer carcinogenesis and survival, and its inhibition by proteosome…”
Get full text